IRLAB, Capital Markets Day, 2023

The Capital Markets Day will provide an opportunity for investors, analysts, and financial media to get an update on IRLAB’s development portfolio and operations as well as its growth strategy. The program will include presentations by the IRLAB’s executive team as well as key external speakers.

Mingel starts 14.00.

Agenda:

14.30 Welcome & introduction - Mats Thoren, Moderator

14.35 Transforming life for people living with Parkinson’s disease - Gunnar Olsson, MD CEO, IRLAB

14.45 Understanding Parkinson’s and its burdenon patients, families, and society - Joakim Tedroff, MD

CMO, IRLAB

14.55 Market opportunities in Parkinson’s and CNS - Peter Wallich Commercial Director, IRLAB

15.05 Mesdopetam: treating levodopa-induced dyskinesias in Parkinson’s (PD-LIDs) -

Nicholas Waters, MD EVP and Head of R&D, IRLAB and Karl Kieburtz, MD, MPH Professor in Neurology, President and co-founder of Parkinson’s

15.50 Preclinical projects and proprietary research platform - Nicholas Waters, PhD

16.00 Panel discussion with a focus on regulatory strategy and business development opportunities.

16:20 Q&A

16:30 Key take aways

If you wish to participate on site, please register on the Attend buttom bellow.